Uncategorized

The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.

July 14, 2025 / Clinical Practice, Uncategorized / InnovateMed Author

Global Regulation By Jessica Hagen | July 7, 2025 | 12:55 PM Photo courtesy of Aktiia Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring System, also known as the Hilo Band. Aktiia’s blood pressure system, known under the Hilo brand in Europe, is a wearable that uses […]

The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026. Read More »

FDA approves Benlysta autoinjector for pediatric patients with active lupus nephritis

July 1, 2025 / Uncategorized / InnovateMed Author / lupus nephritis

by Lori Solomon edited by Sadie Harley, reviewed by Andrew Zinin The U.S. Food and Drug Administration has approved GSK’s autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active lupus nephritis who are receiving standard therapy. Benlysta (200 mg/mL), a B-lymphocyte stimulator-specific inhibiting monoclonal antibody, is the first and only

FDA approves Benlysta autoinjector for pediatric patients with active lupus nephritis Read More »

Novel PDE10A Inhibitor for Acute Schizophrenia Safe, Effective in Large Phase 2 Trial

June 30, 2025 / Research update, Uncategorized / InnovateMed Author / acute schizophrenia

LOS ANGELES — The novel phosphodiesterase 10A (PDE10A) inhibitor known as CPL’36 (Celon Pharma) is effective and generally safe in acute exacerbations of schizophrenia, new research suggested. In a phase 2 trial of 189 patients with acute schizophrenia, compared with the placebo group, the groups receiving CPL’36 20 or 40 mg once daily both met

Novel PDE10A Inhibitor for Acute Schizophrenia Safe, Effective in Large Phase 2 Trial Read More »

A critical link exists among high temps, aging and disease risk

June 25, 2025 / Uncategorized / InnovateMed Author / disease risk

by Carly Murphy, University of California, Irvine edited by Stephanie Baum, reviewed by Robert Egan Credit: Science of The Total Environment (2025). DOI: 10.1016/j.scitotenv.2025.179881 As we age, extreme heat causes many heat-related illnesses that can lead to serious health issues. A new study from the University of California, Irvine’s Joe C. Wen School of Population & Public Health adds

A critical link exists among high temps, aging and disease risk Read More »

What’s the Best Lubricant for Vaginal Dryness?

June 6, 2025 / Uncategorized / InnovateMed Author / vaginal dryness

Written by Maggie Aime, MSN, RN | Reviewed by Sarah Gupta, MD Published on January 30, 2025 Key takeaways: The best lubricant for vaginal dryness depends on your needs. Water-based options are popular but need frequent reapplication. Silicone-based lubricants offer long-lasting moisture, while oil-based options are good for external activities or massage but can damage latex condoms. When

What’s the Best Lubricant for Vaginal Dryness? Read More »

Alzheimer’s gene therapy shows promise in preserving cognitive function

June 5, 2025 / Uncategorized / InnovateMed Author / alzheimer

by University of California – San Diego edited by Gaby Clark, reviewed by Robert Egan This scan of a mouse brain shows blood vessels (red), brain cells (green), and amyloid plaques (blue). A new gene therapy treatment developed by UC San Diego works by reprogramming the behavior of diseased brain cells. Credit: National Center for Advancing Translational

Alzheimer’s gene therapy shows promise in preserving cognitive function Read More »

Deep Learning Can Predict Lung Cancer Risk from Single Ldct Scan

May 22, 2025 / Uncategorized / innovatemednew

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference, and in American Journal of Respiratory and Critical Care Medicine. The model, called Sybil, which was originally developed using National Lung Screening Trial (NLST) data by investigators from the Massachusetts

Deep Learning Can Predict Lung Cancer Risk from Single Ldct Scan Read More »

Is It Better to Shower in the Morning or at Night? Here’s What a Microbiologist Says

May 22, 2025 / Uncategorized / innovatemednew

It’s a question that’s long been the cause of debate: is it better to shower in the morning or at night? Morning shower enthusiasts will say this is the obvious winner, as it helps you wake up and start the day fresh. Night shower loyalists, on the other hand, will argue it’s better to “wash the day

Is It Better to Shower in the Morning or at Night? Here’s What a Microbiologist Says Read More »

Dietary Supplements Rarely Discussed in Primary Care Visits

May 22, 2025 / Uncategorized / innovatemednew / dietary supplements, doctor visits, primary care, supplement discussion

Topline: Although 64.8% of primary care physicians recognized the importance of discussing dietary supplements and possible interaction with medications, a substantial proportion rarely or never addressed them directly during periodic health examinations. Time constraints and competing priorities were identified as the main barriers. Methodology: Researchers conducted a cross-sectional, online questionnaire-based survey to analyze communication behaviors

Dietary Supplements Rarely Discussed in Primary Care Visits Read More »